Jacobs Levy Equity Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-683,835
| Closed | -$17.2M | – | 1112 |
|
|
2020
Q4 | $17.2M | Buy |
683,835
+136,537
| +25% | +$3.44M | 0.15% | 165 |
|
|
2020
Q3 | $11.4M | Buy |
547,298
+90,717
| +20% | +$1.89M | 0.12% | 192 |
|
|
2020
Q2 | $10.8M | Buy |
456,581
+404,362
| +774% | +$9.6M | 0.12% | 202 |
|
|
2020
Q1 | $939K | Buy |
+52,219
| New | +$939K | 0.01% | 640 |
|
|
2018
Q2 | – | Sell |
-12,710
| Closed | -$582K | – | 1100 |
|
|
2018
Q1 | $582K | Buy |
+12,710
| New | +$582K | 0.01% | 753 |
|
|
2015
Q2 | – | Sell |
-15,600
| Closed | -$189K | – | 859 |
|
|
2015
Q1 | $189K | Buy |
+15,600
| New | +$189K | ﹤0.01% | 709 |
|